Literature DB >> 23400413

Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia.

Nicolas Noel, Jean-Marie Michot, Caroline Besson, Cécile Goujard, Olivier Lambotte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23400413     DOI： 10.1007/s12185-013-1288-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials.

Authors:  Tahany Awad; Kristian Thorlund; Goran Hauser; Davor Stimac; Mahasen Mabrouk; Christian Gluud
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

2.  Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1.

Authors:  Q Wang; Y Miyakawa; N Fox; K Kaushansky
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 3.  Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles.

Authors:  R Bruno; P Sacchi; S Cima; L Maiocchi; S Novati; G Filice; S Fagiuoli
Journal:  J Viral Hepat       Date:  2012-01       Impact factor: 3.728

4.  Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.

Authors:  Yesid Alvarado; Jorge Cortes; Srdan Verstovsek; Deborah Thomas; Stephan Faderl; Zeev Estrov; Hagop Kantarjian; Francis J Giles
Journal:  Cancer Chemother Pharmacol       Date:  2002-11-21       Impact factor: 3.333

5.  Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Taghi Manshouri; Rajyalakshmi Luthra; Zeev Estrov; Sherry Pierce; Mary Ann Richie; Gautam Borthakur; Marina Konopleva; Jorge Cortes; Srdan Verstovsek
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

6.  The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types.

Authors:  Herwig P Moll; Thomas Maier; Anna Zommer; Thomas Lavoie; Christine Brostjan
Journal:  Cytokine       Date:  2010-10-12       Impact factor: 3.861
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.